OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Urgent considerations for booster vaccination strategies against Ebola virus disease
Wim Adriaensen, Selien Oostvogels, Yves Lévy, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. e647-e653
Closed Access | Times Cited: 7
Wim Adriaensen, Selien Oostvogels, Yves Lévy, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. e647-e653
Closed Access | Times Cited: 7
Showing 7 citing articles:
Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination
Donovan Guttieres, Charlot Diepvens, Rebecca F. Grais, et al.
PLoS Medicine (2025) Vol. 22, Iss. 2, pp. e1004543-e1004543
Open Access | Times Cited: 1
Donovan Guttieres, Charlot Diepvens, Rebecca F. Grais, et al.
PLoS Medicine (2025) Vol. 22, Iss. 2, pp. e1004543-e1004543
Open Access | Times Cited: 1
One-for-one or one-for-all? Considerations for filovirus vaccine development
Andrea Marzi
PLoS Biology (2025) Vol. 23, Iss. 4, pp. e3003142-e3003142
Open Access | Times Cited: 1
Andrea Marzi
PLoS Biology (2025) Vol. 23, Iss. 4, pp. e3003142-e3003142
Open Access | Times Cited: 1
In silico design of Ebola virus Glycoprotein antigenic peptides as vaccine candidates
David Lara-Ramírez, Clara Esperanza Santacruz-Tinoco, Eva Ramón‐Gallegos, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319496-e0319496
Open Access
David Lara-Ramírez, Clara Esperanza Santacruz-Tinoco, Eva Ramón‐Gallegos, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319496-e0319496
Open Access
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
Richard T. Davey, Gary Collins, Nadine Rouphael, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 11, pp. 100923-100923
Open Access | Times Cited: 1
Richard T. Davey, Gary Collins, Nadine Rouphael, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 11, pp. 100923-100923
Open Access | Times Cited: 1
Ebola disease: bridging scientific discoveries and clinical application
Amanda Rojek, Joshua Fieggen, Paska Apiyo, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1
Amanda Rojek, Joshua Fieggen, Paska Apiyo, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1
Doença Causada por Filovírus: Uma Atualização
Rafael Marx de Andrade, Andreia Paulos, Emília Valadas, et al.
Acta Médica Portuguesa (2024)
Open Access
Rafael Marx de Andrade, Andreia Paulos, Emília Valadas, et al.
Acta Médica Portuguesa (2024)
Open Access
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant
Mohammed Monsoor Shaik, Samuel T. Pasco, Alessio Romerio, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Mohammed Monsoor Shaik, Samuel T. Pasco, Alessio Romerio, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
